✓ Medically Reviewed Monograph

Fluticasone Propionate

Also known as / Synonyms: Fluticasone, Fluticasone furoate

Potent topical and inhaled corticosteroid relieving allergic rhinitis, nasal congestion, and chronic asthma.

Medically reviewed by Dr. Lisa Matthews, PharmD BCPS · Clinical Pharmacist
Written by 4mg Clinical Pharmacology Team Last reviewed ✓ Clinically Verified
📋

Clinical Snapshot & Specifications

Generic Name: Fluticasone Propionate
Active Ingredient: Fluticasone Propionate
Dosage Form: Inhaler
Available Strengths: 50 mcg/actuation nasal spray; 125 mcg, 250 mcg metered dose inhaler (MDI)
Prescription Status: Prescription only (Schedule H / verified)
Popular Verified Brands:
Flixonase Flovent Flomist Flutivate Seroflo (India)
Regulatory Standards: CDSCO approved; Schedule H prescription drug. High topical potency with minimal systemic bioavailability.
🎯

Approved Indications & Medical Uses

  • Seasonal and perennial allergic rhinitis and nonallergic rhinitis (nasal spray).
  • Maintenance treatment of asthma as prophylactic therapy in adults and children (inhaler).
  • Adjunctive treatment of nasal polyps.
  • Inflammatory dermatoses responsive to corticosteroids (topical cream/ointment).
🚫

Contraindications (Do Not Use If…)

  • Primary treatment of status asthmaticus or acute bronchospasm requiring rapid bronchodilator relief.
  • Known hypersensitivity to fluticasone propionate or lactose (in DPI formulations).
  • Untreated localized nasal mucosal infections (herpes simplex, fungal infections).
🛡️

Important Clinical Precautions & Warnings

  • Local candidiasis: oral thrush and hoarseness (dysphonia) can occur with inhalers; advise patients to rinse mouth with water and spit out after each use.
  • Nasal septum perforation: rare with nasal sprays; direct spray away from nasal septum toward outer nostril.
  • Immunosuppression: increased susceptibility to chickenpox, measles, and tuberculosis.
  • Systemic corticosteroid effects: hypercorticism, adrenal suppression, and growth retardation in children with prolonged high-dose use.
  • Glaucoma and cataracts: monitor vision in long-term therapy.

Special Populations (Paediatric & Geriatric Care)

Pediatric: Approved for allergic rhinitis in children >= 4 years. Monitor growth velocity in children on long-term inhaled steroids. Elderly: No dose adjustments needed.

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Epistaxis (nosebleeds), nasal burning/irritation, headache, pharyngitis, hoarseness, and oral candidiasis.

🚨 Serious Side Effects — Seek Urgent Medical Care

Nasal septum ulceration/perforation, adrenal insufficiency upon withdrawal, severe bronchospasm, anaphylaxis, and glaucoma.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • Strong CYP3A4 inhibitors (ritonavir, ketoconazole, clarithromycin): significantly increase fluticasone plasma levels, causing systemic corticosteroid effects and Cushingoid features.
  • Other systemic steroids: additive hypothalamic-pituitary-adrenal (HPA) axis suppression.
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Use with caution — see notes

Preferred inhaled/intranasal steroid in pregnancy due to vast safety data and low systemic bioavailability; asthma control is critical for fetal oxygenation.

Lactation & Breastfeeding:

Use with caution — see notes

Extremely low concentrations in maternal plasma make clinically significant excretion in breast milk unlikely.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store upright between 15°C and 30°C. Shake nasal spray well before priming. Do not puncture or incinerate pressurized canisters.

⏱️ Missed Dose Protocol:

Administer on a regular daily schedule. If missed, take upon remembering unless time for next scheduled puff/spray. Never double dose.

📚

Clinical Sources & Regulatory References

Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.

Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:

🏛️ CDSCO (Govt. of India)

Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).

CDSCO Official Portal →
🇺🇸 U.S. FDA / DailyMed

U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.

Search FDA Labels on DailyMed →
🌐 World Health Organization

WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).

WHO Essential Medicines Registry →
🔬 PubMed / NLM

National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.

Query PubMed Studies for Fluticasone Propionate →
Suggested Monograph Citation:

4mg Clinical Pharmacology Team. Fluticasone Propionate Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/fluticasone/

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.